These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A cytokine-selective defect in interleukin-1 beta-mediated acute phase gene expression in a subclone of the human hepatoma cell line (HEPG2). Perlmutter DH; Colten HR; Adams SP; May LT; Sehgal PB; Fallon RJ J Biol Chem; 1989 May; 264(13):7669-74. PubMed ID: 2468672 [TBL] [Abstract][Full Text] [Related]
3. Regulation of hepatic acute phase protein synthesis by products of interleukin 2 (IL 2)-stimulated human peripheral blood mononuclear cells. Mier JW; Dinarello CA; Atkins MB; Punsal PI; Perlmutter DH J Immunol; 1987 Aug; 139(4):1268-72. PubMed ID: 2440951 [TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression. Pardo-Saganta A; Latasa MU; Castillo J; Alvarez-Asiain L; Perugorría MJ; Sarobe P; Rodriguez-Ortigosa CM; Prieto J; Berasain C; Santamaría M; Avila MA J Hepatol; 2009 Dec; 51(6):1010-20. PubMed ID: 19815304 [TBL] [Abstract][Full Text] [Related]
5. Regulation of class III major histocompatibility complex gene products by interleukin-1. Perlmutter DH; Goldberger G; Dinarello CA; Mizel SB; Colten HR Science; 1986 May; 232(4752):850-2. PubMed ID: 3010455 [TBL] [Abstract][Full Text] [Related]
6. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. Mackiewicz A; Speroff T; Ganapathi MK; Kushner I J Immunol; 1991 May; 146(9):3032-7. PubMed ID: 1707930 [TBL] [Abstract][Full Text] [Related]
7. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040 [TBL] [Abstract][Full Text] [Related]
8. Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma Hep 3B cells. Beuscher HU; Fallon RJ; Colten HR J Immunol; 1987 Sep; 139(6):1896-901. PubMed ID: 2442260 [TBL] [Abstract][Full Text] [Related]
9. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 regulates production of acute-phase proteins. Mackiewicz A; Ganapathi MK; Schultz D; Brabenec A; Weinstein J; Kelley MF; Kushner I Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1491-5. PubMed ID: 1689487 [TBL] [Abstract][Full Text] [Related]
11. Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines. Mackiewicz A; Schultz D; Mathison J; Ganapathi M; Kushner I Clin Exp Immunol; 1989 Jan; 75(1):70-5. PubMed ID: 2467770 [TBL] [Abstract][Full Text] [Related]
12. TNF-alpha, IL-1 beta, and hepatocyte growth factor cooperate in stimulating specific acute phase plasma protein genes in rat hepatoma cells. Baumann H; Morella KK; Wong GH J Immunol; 1993 Oct; 151(8):4248-57. PubMed ID: 7691942 [TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. Morrone G; Ciliberto G; Oliviero S; Arcone R; Dente L; Content J; Cortese R J Biol Chem; 1988 Sep; 263(25):12554-8. PubMed ID: 2457587 [TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. Falus A; Rokita H; Walcz E; Brozik M; Hidvégi T; Merétey K Mol Immunol; 1990 Feb; 27(2):197-201. PubMed ID: 2157145 [TBL] [Abstract][Full Text] [Related]
15. Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Andus T; Geiger T; Hirano T; Kishimoto T; Heinrich PC Eur J Immunol; 1988 May; 18(5):739-46. PubMed ID: 2454192 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. Sipe JD; Vogel SN; Douches S; Neta R Lymphokine Res; 1987; 6(2):93-101. PubMed ID: 3495710 [TBL] [Abstract][Full Text] [Related]
17. Expression of complement proteins C2 and factor B in transfected L cells. Perlmutter DH; Colten HR; Grossberger D; Strominger J; Seidman JG; Chaplin DD J Clin Invest; 1985 Oct; 76(4):1449-54. PubMed ID: 3850903 [TBL] [Abstract][Full Text] [Related]
18. IL-1 receptor antagonist affects the plasma protein response of Hep 3B cells to conditioned medium from lipopolysaccharide-stimulated monocytes. Damtew B; Rzewnicki D; Lozanski G; Kushner I J Immunol; 1993 May; 150(9):4001-7. PubMed ID: 7682588 [TBL] [Abstract][Full Text] [Related]
19. Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters. Evans E; Courtois GM; Kilian PL; Fuller GM; Crabtree GR J Biol Chem; 1987 Aug; 262(22):10850-4. PubMed ID: 2440878 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase. Li N; Klaassen CD Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]